Perfil
Steven M.
Toler served as Vice President-Pharmaceutical Development at Bellicum Pharmaceuticals, Inc. from 2015 to 2018 and as Vice President-Clinical Pharmaceutical Sciences at Targacept, Inc. from 2013 to 2015.
He holds a doctorate degree from Mercer University and Chandler Medical Center, and an undergraduate degree from Georgia State University.
Antiguos cargos conocidos de Steven M. Toler.
| Empresas | Cargo | Fin |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2018 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Corporate Officer/Principal | 31/03/2015 |
Formación de Steven M. Toler.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
Mercer University
Mercer University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Health Technology |
Georgia State University
Georgia State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chandler Medical Center
Chandler Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Bolsa de valores
- Insiders
- Steven M. Toler
















